Chronic inflammatory diseases are associated with accelerated atherosclerosis and
increased risk of cardiovascular diseases (CVD). As the pathogenesis of atherosclerosis is …

Objectives: To develop evidence-based EULAR recommendations for cardiovascular (CV)
risk management in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and …

Inflammation is a stereotypical physiological response to infections and tissue injury; it
initiates pathogen killing as well as tissue repair processes and helps to restore …

Background Rheumatoid arthritis is characterised by inflammatory synovitis, articular
destruction, and accelerated atherogenesis. HMG-CoA (3-hydroxy-3 …

Background—Rheumatoid arthritis (RA) is associated with increased cardiovascular risk,
which is not explained by traditional cardiovascular risk factors but may be due in part to …

OBJECTIVES: Rheumatoid arthritis (RA) is a systemic inflammatory disease associated with
an increased prevalence of coronary heart disease and a high cardiovascular (CV) mortality …

Chronic inflammatory rheumatic diseases (IRD), including rheumatoid arthritis, ankylosing
spondylitis, and psoriatic arthritis, are prevalent conditions worldwide, with a considerable …

Rationale: Impaired vascular reactivity is an important factor in the pathogenesis of
cardiovascular disease. Objectives: We sought to assess vascular reactivity in patients with …

Cardiovascular disease (CV) is the most common cause of premature mortality in patients
with rheumatoid arthritis (RA). This is the result of an accelerated atherosclerotic process …

Immunologic research into pathogenic mechanisms operating in autoimmune-mediated
atherosclerosis initially focused on adaptive immunity. Current interest is directed to more …